Relapsed or Refractory Solid Tumors
3 clinical trials · Condition
◉ Watch Relapsed or Refractory Solid Tumors
| Record | Firm | Date |
|---|---|---|
| A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080) (NCT04447755) | Merck Sharp & Dohme LLC | 2020-07-30 |
| Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer (NCT02963610) | Fox Chase Cancer Center | 2017-03-29 |
| A Dose Escalation Study of OMP-52M51 in Subjects With Solid Tumors (NCT01778439) | OncoMed Pharmaceuticals, Inc. | 2013-02-01 |
Track Relapsed or Refractory Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.